{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:49:41Z","timestamp":1782470981193,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12185-026-04176-4","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:28:02Z","timestamp":1770564482000},"page":"802-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Designing immune reconstitution to prevent graft-versus-host disease: a novel therapeutic paradigm beyond T cell suppression"],"prefix":"10.1007","volume":"123","author":[{"given":"Ken-ichi","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"4176_CR1","first-page":"21","volume":"62","author":"RE Billingham","year":"1966","unstructured":"Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966;62:21\u201378.","journal-title":"Harvey Lect"},{"issue":"4379","key":"4176_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/172603a0","volume":"172","author":"RE Billingham","year":"1953","unstructured":"Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603\u20136. https:\/\/doi.org\/10.1038\/172603a0.","journal-title":"Nature"},{"issue":"5","key":"4176_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0952-7915(93)90139-j","volume":"5","author":"JL Ferrara","year":"1993","unstructured":"Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5(5):794\u20139. https:\/\/doi.org\/10.1016\/0952-7915(93)90139-j.","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"4176_CR4","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90(8):3204\u201313.","journal-title":"Blood"},{"issue":"5426","key":"4176_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1126\/science.285.5426.412","volume":"285","author":"WD Shlomchik","year":"1999","unstructured":"Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285(5426):412\u20135. https:\/\/doi.org\/10.1126\/science.285.5426.412.","journal-title":"Science"},{"issue":"6","key":"4176_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nm0602-575","volume":"8","author":"T Teshima","year":"2002","unstructured":"Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575\u201381. https:\/\/doi.org\/10.1038\/nm0602-575.","journal-title":"Nat Med"},{"issue":"2","key":"4176_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1084\/jem.20101559","volume":"208","author":"S Takashima","year":"2011","unstructured":"Takashima S, Kadowaki M, Aoyama K, Koyama M, Oshima T, Tomizuka K, et al. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells. J Exp Med. 2011;208(2):285\u201394. https:\/\/doi.org\/10.1084\/jem.20101559.","journal-title":"J Exp Med"},{"issue":"2","key":"4176_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash AM, Dudakov JA, Hua G, O\u2019Connor MH, Young LF, Singer NV, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft-versus-host disease. Immunity. 2012;37(2):339\u201350. https:\/\/doi.org\/10.1016\/j.immuni.2012.05.028.","journal-title":"Immunity"},{"issue":"1","key":"4176_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1182\/blood-2011-12-401166","volume":"120","author":"Y Eriguchi","year":"2012","unstructured":"Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of \u03b1-defensins. Blood. 2012;120(1):223\u201331. https:\/\/doi.org\/10.1182\/blood-2011-12-401166.","journal-title":"Blood"},{"issue":"18","key":"4176_CR10","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2017-06-792614","volume":"131","author":"S Takahashi","year":"2018","unstructured":"Takahashi S, Hashimoto D, Hayase E, Ogasawara R, Ohigashi H, Ara T, et al. Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease. Blood. 2018;131(18):2074\u201385. https:\/\/doi.org\/10.1182\/blood-2017-06-792614.","journal-title":"Blood"},{"issue":"8","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2023023060","volume":"144","author":"Y Hasegawa","year":"2024","unstructured":"Hasegawa Y, Hashimoto D, Zhang Z, Miyajima T, Saito Y, Li W, et al. GVHD targets organoid-forming bile duct stem cells in a TGF-\u03b2-dependent manner. Blood. 2024;144(8):904\u201313. https:\/\/doi.org\/10.1182\/blood.2023023060.","journal-title":"Blood"},{"issue":"18","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1182\/blood.2021011867","volume":"138","author":"R Chakraverty","year":"2021","unstructured":"Chakraverty R, Teshima T. Graft-versus-host disease: a disorder of tissue regeneration and repair. Blood. 2021;138(18):1657\u201365. https:\/\/doi.org\/10.1182\/blood.2021011867.","journal-title":"Blood"},{"issue":"9","key":"4176_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1900623.","journal-title":"N Engl J Med"},{"issue":"1","key":"4176_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13498-3","volume":"10","author":"D Michonneau","year":"2019","unstructured":"Michonneau D, Latis E, et al. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat Commun. 2019;10(1):5695. https:\/\/doi.org\/10.1038\/s41467-019-13498-3.","journal-title":"Nat Commun"},{"issue":"11","key":"4176_CR15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41590-021-01048-3","volume":"22","author":"H Fujiwara","year":"2021","unstructured":"Fujiwara H, Seike K, Brooks MD, Mathew AV, Kovalenko I, Pal A, et al. Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol. 2021;22(11):1440\u201351. https:\/\/doi.org\/10.1038\/s41590-021-01048-3.","journal-title":"Nat Immunol"},{"issue":"2","key":"4176_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2023.01.007","volume":"56","author":"K Seike","year":"2023","unstructured":"Seike K, Kiledal A, Fujiwara H, Henig I, da Burgos Silva M, van den Brink MRM, et al. Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation. Immunity. 2023;56(2):353-368.e6. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.007.","journal-title":"Immunity"},{"key":"4176_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-024-07667-8","volume":"632","author":"K Fujimoto","year":"2024","unstructured":"Fujimoto K, Hayashi T, et al. An enterococcal phage-derived enzyme suppresses graft-versus-host disease. Nature. 2024;632:174\u201381. https:\/\/doi.org\/10.1038\/s41586-024-07667-8.","journal-title":"Nature"},{"issue":"1","key":"4176_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05577-x","volume":"22","author":"L Han","year":"2024","unstructured":"Han L, Sun X, et al. Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism. J Transl Med. 2024;22(1):746. https:\/\/doi.org\/10.1186\/s12967-024-05577-x.","journal-title":"J Transl Med"},{"key":"4176_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.011","author":"M Koyama","year":"2019","unstructured":"Koyama M, et al. MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity. 2019. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.011.","journal-title":"Immunity"},{"issue":"8","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20150329","volume":"212","author":"M Koyama","year":"2015","unstructured":"Koyama M, et al. Alloantigen presentation by the intestinal epithelium drives GVHD. J Exp Med. 2015;212(8):1303\u201321.","journal-title":"J Exp Med"},{"issue":"24","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2016-02-697250","volume":"127","author":"M Koyama","year":"2016","unstructured":"Koyama M, Hill GR. Alloantigen presentation and graft-versus-host disease: fuel for the fire. Blood. 2016;127(24):2963\u201370. https:\/\/doi.org\/10.1182\/blood-2016-02-697250.","journal-title":"Blood"},{"issue":"24","key":"4176_CR22","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood-20","volume":"134","author":"M Koyama","year":"2019","unstructured":"Koyama M, Hill GR. The primacy of gastrointestinal tract antigen-presenting cells in lethalgraft-versus-host disease. Blood. 2019;134(24):2139\u201348. https:\/\/doi.org\/10.1182\/blood-20.","journal-title":"Blood"},{"issue":"6","key":"4176_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1182\/blood-2013-11-539031","volume":"124","author":"A Mensen","year":"2014","unstructured":"Mensen A, J\u00f6hrens K, Anagnostopoulos I, et al. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT. Blood. 2014;124(6):963\u201372. https:\/\/doi.org\/10.1182\/blood-2013-11-539031.","journal-title":"Blood"},{"issue":"26","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1182\/blood-2009-11-253559","volume":"115","author":"Y Shono","year":"2010","unstructured":"Shono Y, Ueha S, Wang Y, Abe J, Kurachi M, Matsuno Y, et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood. 2010;115(26):5401\u201311. https:\/\/doi.org\/10.1182\/blood-2009-11-253559.","journal-title":"Blood"},{"issue":"5","key":"4176_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI40088","volume":"120","author":"K Matsuoka","year":"2010","unstructured":"Matsuoka K, et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Investig. 2010;120(5):1479\u201393. https:\/\/doi.org\/10.1172\/JCI40088.","journal-title":"J Clin Investig"},{"issue":"8","key":"4176_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162180","volume":"8","author":"Y Sumii","year":"2023","unstructured":"Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura MF, et al. Hematopoietic stem cell\u2013derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023;8(8):e162180. https:\/\/doi.org\/10.1172\/jci.insight.162180.","journal-title":"JCI Insight"},{"key":"4176_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114368","volume":"14","author":"B Obermayer","year":"2023","unstructured":"Obermayer B, et al. Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation. Front Immunol. 2023;14:1114368. https:\/\/doi.org\/10.3389\/fimmu.2023.1114368.","journal-title":"Front Immunol"},{"issue":"2","key":"4176_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.immuni.2023.01.003","volume":"56","author":"F Sacirbegovic","year":"2023","unstructured":"Sacirbegovic F, G\u00fcnther M, Greco A, Zhao D, Wang X, Zhou M, et al. Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. Immunity. 2023;56(2):369-385.e6. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.003.","journal-title":"Immunity"},{"key":"4176_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","volume":"21","author":"E Velardi","year":"2021","unstructured":"Velardi E, Tsai JJ, van den Brink MRM. T cell regeneration after immunological injury. Nat Rev Immunol. 2021;21:277\u201391. https:\/\/doi.org\/10.1038\/s41577-020-00457-z.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4176_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","volume":"36","author":"PJ Siska","year":"2015","unstructured":"Siska PJ, Rathmell JC. T cell metabolic fitness in antitumor immunity. Trends Immunol. 2015;36(4):257\u201364. https:\/\/doi.org\/10.1016\/j.it.2015.02.007.","journal-title":"Trends Immunol"},{"issue":"4","key":"4176_CR31","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1172\/JCI82587","volume":"126","author":"DN Hung","year":"2016","unstructured":"Hung DN, Chatterjee S, Haarberg KMK, Wu Y, Bastian D, Heinrichs J, et al. Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation. J Clin Investig. 2016;126(4):1337\u201352. https:\/\/doi.org\/10.1172\/JCI82587.","journal-title":"J Clin Investig"},{"issue":"19","key":"4176_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.181568","volume":"10","author":"K Quann","year":"2025","unstructured":"Quann K, Sacirbegovic F, Rosenberger S, McFerran ER, Codispot KC, Garcia-Dieguez L, et al. The role of TCF-1+CD8+ exhausted progenitors and TCF-1 in graft-versus-host responses. JCI Insight. 2025;10(19):e181568. https:\/\/doi.org\/10.1172\/jci.insight.181568.","journal-title":"JCI Insight"},{"issue":"5","key":"4176_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood.2023019875","volume":"142","author":"H Senjo","year":"2023","unstructured":"Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, et al. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023;142(5):477\u201392. https:\/\/doi.org\/10.1182\/blood.2023019875.","journal-title":"Blood"},{"issue":"5","key":"4176_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86252","volume":"1","author":"CG Kanakry","year":"2016","unstructured":"Kanakry CG, et al. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight. 2016;1(5):e86252. https:\/\/doi.org\/10.1172\/jci.insight.86252.","journal-title":"JCI Insight"},{"issue":"17","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1182\/bloodadvances.2022006961","volume":"6","author":"MT Patterson","year":"2022","unstructured":"Patterson MT, et al. Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide. Blood Adv. 2022;6(17):4994\u20135008. https:\/\/doi.org\/10.1182\/bloodadvances.2022006961.","journal-title":"Blood Adv"},{"issue":"8","key":"4176_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood.2024026633","volume":"145","author":"SJ Lee","year":"2025","unstructured":"Lee SJ, Zeiser R. FDA-approved therapies for chronic GVHD. Blood. 2025;145(8):795\u2013800. https:\/\/doi.org\/10.1182\/blood.2024026633.","journal-title":"Blood"},{"issue":"6","key":"4176_CR37","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1158\/2767-9764.CRC-24-0138","volume":"4","author":"A Rashidi","year":"2024","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, et al. Multi-omics analysis of a fecal microbiota transplantation trial identifies novel aspects of acute GVHD pathogenesis. Cancer Res Commun. 2024;4(6):1454\u201366. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0138.","journal-title":"Cancer Res Commun"},{"issue":"8","key":"4176_CR38","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/s41591-024-03016-4","volume":"30","author":"YB Chen","year":"2024","unstructured":"Chen YB, Mohty M, Zeiser R, Teshima T, Jamy O, Maertens J, et al. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nat Med. 2024;30(8):2277\u201387. https:\/\/doi.org\/10.1038\/s41591-024-03016-4.","journal-title":"Nat Med"},{"issue":"15","key":"4176_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162201","volume":"133","author":"Y Lin","year":"2023","unstructured":"Lin Y, Gu Q, Lu S, Pan Z, Yang Z, Li Y, et al. Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. J Clin Invest. 2023;133(15):e162201. https:\/\/doi.org\/10.1172\/JCI162201.","journal-title":"J Clin Invest"},{"issue":"18","key":"4176_CR40","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1182\/blood.2024026446","volume":"145","author":"EH Meyer","year":"2025","unstructured":"Meyer EH, Pavlova A, Villar-Prados A, Bader C, Xie B, Muffly L, et al. Donor regulatory T-cell therapy to prevent graft-versus-host disease. Blood. 2025;145(18):2012\u201324. https:\/\/doi.org\/10.1182\/blood.2024026446.","journal-title":"Blood"},{"key":"4176_CR41","doi-asserted-by":"publisher","unstructured":"Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365(22):2055\u201366. https:\/\/doi.org\/10.1056\/NEJMoa1108188.","DOI":"10.1056\/NEJMoa1108188"},{"issue":"179","key":"4176_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005265","volume":"5","author":"K Matsuoka","year":"2013","unstructured":"Matsuoka K, Koreth J, Kim HT, Bascug G, McDonough S, Kawano Y, et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci Transl Med. 2013;5(179):179ra43. https:\/\/doi.org\/10.1126\/scitranslmed.3005265.","journal-title":"Sci Transl Med"},{"key":"4176_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.713358","volume":"12","author":"S Ikegawa","year":"2021","unstructured":"Ikegawa S, Matsuoka KI. Harnessing Treg homeostasis to optimize posttransplant immunity: current concepts and future perspectives. Front Immunol. 2021;12:713358. https:\/\/doi.org\/10.3389\/fimmu.2021.713358.","journal-title":"Front Immunol"},{"issue":"50","key":"4176_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba5264","volume":"5","author":"L Khoryati","year":"2020","unstructured":"Khoryati L, Pham MN, Sherve M, Kumari S, Cook K, Pearson J, et al. An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice. Sci Immunol. 2020;5(50):eaba5264. https:\/\/doi.org\/10.1126\/sciimmunol.aba5264.","journal-title":"Sci Immunol"},{"issue":"Supplement 1","key":"4176_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2024-200128","volume":"144","author":"S Ikegawa","year":"2024","unstructured":"Ikegawa S, Asano T, et al. Heterogeneity of PD-1+ regulatory T cells after low-dose IL-2 therapy for patients with chronic graft-versus-host disease. Blood. 2024;144(Supplement 1):379.","journal-title":"Blood"},{"key":"4176_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104220","volume":"358","author":"I Rosado-S\u00e1nchez","year":"2020","unstructured":"Rosado-S\u00e1nchez I, Levings MK. Building a CAR-Treg: going from the basic to the luxury model. Cell Immunol. 2020;358:104220. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104220.","journal-title":"Cell Immunol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04176-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:09:10Z","timestamp":1782468550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04176-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04176-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}